![Scott Sukenick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 59 275 $ al 31/05/2026
Scott Sukenick is Secretary & Chief Legal Officer at SCYNEXIS, Inc. since 2023.
Mr. Sukenick was Senior Associate at Cooley LLP from 2012 to 2017.
Mr. Sukenick completed graduate education at Harvard University and undergraduate education at Duke University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SCYNEXIS, INC. 0,11 % | 01/04/2026 | 84.078 ( 0,11 % ) | 59 275 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SCYNEXIS, INC. | Consejero General | 15/11/2017 |
| Empresas | Cargo | Fin |
|---|---|---|
Cooley LLP
 Cooley LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01/11/2017 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SCYNEXIS, Inc.
 SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections | Health Technology |
Cooley LLP
Cooley LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
